Skip to main content
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

More about this publication?
Volume 6, Number 2, 2005

Book review

Favourites:
ADD

Review article

The Role of Apolipoprotein AIV on the Control of Food Intake
pp. 145-151(7)
Authors: Qin, Xiaofa; Tso, Patrick

Favourites:
ADD

Ghrelin and Energy Balance: Focus on Current Controversies
pp. 153-169(17)
Authors: Cummings, David E.; Foster-Schubert, Karen E.; Overduin, Joost

Favourites:
ADD

Peptide YY: A Potential Therapy for Obesity
pp. 171-179(9)
Authors: Renshaw, D.; Batterham, R. L.

Favourites:
ADD

Pancreatic Amylin as a Centrally Acting Satiating Hormone
pp. 181-189(9)
Author: Lutz, Thomas A.

Favourites:
ADD

Modulation of Eating by Central Catecholamine Systems
pp. 191-199(9)
Author: Wellman, Paul J.

Favourites:
ADD

Serotonin (5-HT) Drugs: Effects on Appetite Expression and Use for the Treatment of Obesity
pp. 201-213(13)
Authors: Halford, Jason C.G.; Harrold, Joanne A.; Lawton, Clare L.; Blundell, John E.

Favourites:
ADD

Cannabinoids and the Regulation of Ingestive Behaviour
pp. 215-223(9)
Authors: Vickers, S. P.; Kennett, G. A.

Favourites:
ADD

The Hypothalamus and Obesity
pp. 225-240(16)
Author: King, Peter J.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content